Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in PPBT — Purple Biotech Ltd.

CIK 1115418 BOSTON, MA
Back to PPBT Full portfolio

Position in PPBT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,438
-$1,430 QoQ
Shares Held
856
+20.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 13 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PPBT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PPBT ranks #321 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in PPBT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,438 856
2026-03-31 $2,868 710
2025-12-31 $4,863 7,392
2025-09-30 $619 1,080
2025-06-30 $2,532 1,080
2025-03-31 $2,141 805
2024-12-31 $2,837 605
2024-06-30 $6 16
2024-03-31 $10 16
2023-12-31 $432 555
2023-09-30 $660 555
2023-06-30 $774 555